BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu XL, Du YZ, Yu RS, Liu P, Shi D, Chen Y, Wang Y, Huang FF. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate. Int J Mol Sci 2013;14:15755-66. [PMID: 23899789 DOI: 10.3390/ijms140815755] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Thakur Kumar V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistance. Expert Opin Drug Deliv 2022. [PMID: 35152815 DOI: 10.1080/17425247.2022.2041598] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
2 El-Mehalmey WA, Latif N, Ibrahim AH, Haikal RR, Mierzejewska P, Smolenski RT, Yacoub MH, Alkordi MH. Nine days extended release of adenosine from biocompatible MOFs under biologically relevant conditions. Biomater Sci 2022. [PMID: 35107101 DOI: 10.1039/d1bm01519b] [Reference Citation Analysis]
3 Fawzi Kabil M, Nasr M, El-Sherbiny IM. Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. Eur J Pharm Biopharm 2021;167:9-37. [PMID: 34271117 DOI: 10.1016/j.ejpb.2021.07.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Zhai X, Li C, Ren D, Wang J, Ma C, Abd El-Aty AM. The impact of chitooligosaccharides and their derivatives on the in vitro and in vivo antitumor activity: A comprehensive review. Carbohydr Polym 2021;266:118132. [PMID: 34044948 DOI: 10.1016/j.carbpol.2021.118132] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
5 Zheng Z, Pan X, Xu J, Wu Z, Zhang Y, Wang K. Advances in tracking of polysaccharides in vivo: Labeling strategies, potential factors and applications based on pharmacokinetic characteristics. International Journal of Biological Macromolecules 2020;163:1403-20. [DOI: 10.1016/j.ijbiomac.2020.07.210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Caprifico AE, Polycarpou E, Foot PJS, Calabrese G. Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan-Based Nanocarriers. Macromol Biosci 2021;21:e2000312. [PMID: 33016007 DOI: 10.1002/mabi.202000312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Bonferoni MC, Gavini E, Rassu G, Maestri M, Giunchedi P. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials (Basel) 2020;10:E870. [PMID: 32365938 DOI: 10.3390/nano10050870] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
8 Xing L, Fan Y, Shen L, Yang C, Liu X, Ma Y, Qi L, Cho K, Cho C, Jiang H. pH-sensitive and specific ligand-conjugated chitosan nanogels for efficient drug delivery. International Journal of Biological Macromolecules 2019;141:85-97. [DOI: 10.1016/j.ijbiomac.2019.08.237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
9 Elnaggar MH, Abushouk AI, Hassan AHE, Lamloum HM, Benmelouka A, Moatamed SA, Abd-Elmegeed H, Attia S, Samir A, Amr N, Johar D, Zaky S. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Semin Cancer Biol 2021;69:91-9. [PMID: 31421265 DOI: 10.1016/j.semcancer.2019.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
10 Qindeel M, Ahmed N, Khan GM, Rehman AU. Ligand decorated chitosan as an advanced nanocarrier for targeted delivery: a critical review. Nanomedicine (Lond) 2019;14:1623-42. [PMID: 31166147 DOI: 10.2217/nnm-2018-0490] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
11 Naveed M, Phil L, Sohail M, Hasnat M, Baig MMFA, Ihsan AU, Shumzaid M, Kakar MU, Mehmood Khan T, Akabar M, Hussain MI, Zhou Q. Chitosan oligosaccharide (COS): An overview. International Journal of Biological Macromolecules 2019;129:827-43. [DOI: 10.1016/j.ijbiomac.2019.01.192] [Cited by in Crossref: 106] [Cited by in F6Publishing: 152] [Article Influence: 35.3] [Reference Citation Analysis]
12 Alamry KA, Hussein MA, Al-ghamdi YO, Saleh TS, Asiri AM, Alhebshi AM, Weaver GW. Potential anti-cancer performance of chitosan-based β-ketosulfone derivatives. Cogent Chemistry 2018;4:1559435. [DOI: 10.1080/23312009.2018.1559435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
13 Zhang YQ, Shen Y, Liao MM, Mao X, Mi GJ, You C, Guo QY, Li WJ, Wang XY, Lin N, Webster TJ. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine 2019;15:86-97. [PMID: 30244085 DOI: 10.1016/j.nano.2018.09.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
14 Wang C, Zhang Z, Chen B, Gu L, Li Y, Yu S. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. Journal of Colloid and Interface Science 2018;516:332-41. [DOI: 10.1016/j.jcis.2018.01.073] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 13.3] [Reference Citation Analysis]
15 Hong SJ, Ahn MH, Sangshetti J, Choung PH, Arote RB. Sugar-based gene delivery systems: Current knowledge and new perspectives. Carbohydrate Polymers 2018;181:1180-93. [DOI: 10.1016/j.carbpol.2017.11.105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
16 Dong H, Tian L, Gao M, Xu H, Zhang C, Lv L, Zhang J, Wang C, Tian Y, Ma X. Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy. Drug Deliv 2017;24:1302-16. [PMID: 28895767 DOI: 10.1080/10717544.2017.1373165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
17 Le Thi TN, Nguyen TH, Hoang DQ, Tran TV, Nguyen NT, Nguyen DH. Development of new magnetic nanoparticles: Oligochitosan obtained by γ-rays and –coated Fe3O4 nanoparticles. Applied Surface Science 2017;422:863-8. [DOI: 10.1016/j.apsusc.2017.06.115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
18 Chen J, Chen Y, Cheng Y, Gao Y, Zheng P, Li C, Tong Y, Li Z, Luo W, Chen Z. Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations. Oncotarget 2017;8:102046-66. [PMID: 29254224 DOI: 10.18632/oncotarget.22143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
19 Mohamed NK, Hamad MA, Hafez MZ, Wooley KL, Elsabahy M. Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities: Nanomedicine in management of HCC. Int J Cancer 2017;140:1475-84. [DOI: 10.1002/ijc.30517] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
20 Kiaie N, Aghdam RM, Tafti SH, Emami SH. Statistical optimization of chitosan nanoparticles as protein vehicles, using response surface methodology. J Appl Biomater Funct Mater 2016;14:e413-22. [PMID: 27647390 DOI: 10.5301/jabfm.5000278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Muanprasat C, Chatsudthipong V. Chitosan oligosaccharide: Biological activities and potential therapeutic applications. Pharmacol Ther. 2017;170:80-97. [PMID: 27773783 DOI: 10.1016/j.pharmthera.2016.10.013] [Cited by in Crossref: 195] [Cited by in F6Publishing: 242] [Article Influence: 32.5] [Reference Citation Analysis]
22 Kazemzadeh-Narbat M, Annabi N, Tamayol A, Oklu R, Ghanem A, Khademhosseini A. Adenosine-associated delivery systems. J Drug Target 2015;23:580-96. [PMID: 26453156 DOI: 10.3109/1061186X.2015.1058803] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
23 Gaudin A, Lepetre-Mouelhi S, Mougin J, Parrod M, Pieters G, Garcia-Argote S, Loreau O, Goncalves J, Chacun H, Courbebaisse Y, Clayette P, Desmaële D, Rousseau B, Andrieux K, Couvreur P. Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis. J Control Release 2015;212:50-8. [PMID: 26087468 DOI: 10.1016/j.jconrel.2015.06.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
24 D'souza AA, Devarajan PV. Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications. Journal of Controlled Release 2015;203:126-39. [DOI: 10.1016/j.jconrel.2015.02.022] [Cited by in Crossref: 210] [Cited by in F6Publishing: 243] [Article Influence: 30.0] [Reference Citation Analysis]
25 Varshosaz J, Taymouri S, Hassanzadeh F, Javanmard SH, Rostami M. Folated synperonic-cholesteryl hemisuccinate polymeric micelles for the targeted delivery of docetaxel in melanoma. Biomed Res Int. 2015;2015:746093. [PMID: 25839040 DOI: 10.1155/2015/746093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
26 Azuma K, Osaki T, Minami S, Okamoto Y. Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides. J Funct Biomater 2015;6:33-49. [PMID: 25594943 DOI: 10.3390/jfb6010033] [Cited by in Crossref: 142] [Cited by in F6Publishing: 139] [Article Influence: 20.3] [Reference Citation Analysis]
27 Yang Y, Yuan S, Zhao L, Wang C, Ni J, Wang Z, Lin C, Wu M, Zhou W. Ligand-Directed Stearic Acid Grafted Chitosan Micelles to Increase Therapeutic Efficacy in Hepatic Cancer. Mol Pharmaceutics 2015;12:644-52. [DOI: 10.1021/mp500723k] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
28 da Costa JP, Oliveira-silva R, Daniel-da-silva AL, Vitorino R. Bionanoconjugation for Proteomics applications — An overview. Biotechnology Advances 2014;32:952-70. [DOI: 10.1016/j.biotechadv.2014.04.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
29 Rohilla R, Garg T, Goyal AK, Rath G. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Delivery 2016. [DOI: 10.3109/10717544.2014.945018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
30 Dangi R, Hurkat P, Jain A, Shilpi S, Jain A, Gulbake A, Jain SK. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles. Journal of Microencapsulation 2014;31:479-87. [DOI: 10.3109/02652048.2013.879929] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
31 Yu RS, Zhu XL, Sun JZ, Shi D, Chen Y, Wang ZK, Tang KZ, Du YZ. Preliminary Study on Hepatocyte-Targeted Phosphorus-31 MRS Using ATP-Loaded Galactosylated Chitosan Oligosaccharide Nanoparticles. Gastroenterol Res Pract 2013;2013:512483. [PMID: 24363667 DOI: 10.1155/2013/512483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Kozlova D, Epple M. Biological targeting with nanoparticles: state of the art. BioNanoMaterials 2013;14. [DOI: 10.1515/bnm-2013-0020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]